Bode John B
SEC CIK 1612084 · EDGAR
BoughtSold
Most active insiders at ZVRA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | McFarlane Neil F. | Pres, CEO, Dir | — | $1.19M |
| 2 | Thompson Rahsaan | Chief Legal, Compliance, Sec | — | $969.4K |
| 3 | Watton Corey Michael | Dir | — | $138.4K |
| 4 | Schafer Joshua | CCO | — | $126.3K |
| 5 | Sangiovanni Timothy J. | SVP, Fin, Corp Ctrl | — | $43.0K |
| 6 | Quartel Adrian W | Chief Medical Off | — | $40.0K |
| 7 | Bode John B | Dir | — | — |
| 8 | Clifton R. LaDuane | Former CFO, Treas | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-26 | 2026-03-24 | ZVRA | ZEVRA THERAPEUTICS, INC. | Bode John B | Dir | M - OptEx | $4.93 | +78.4K | 123.4K | +174% | +$386.5K |
| 2026-02-03 | 2026-01-30 | NWTG | Newton Golf Company, Inc. | Bode John B | Dir | A - Grant | $0.00 | +18.5K | 18.5K | New | $0 | |
| 2025-08-20 | 2025-08-19 | ZVRA | ZEVRA THERAPEUTICS, INC. | Bode John B | Dir | P - Purchase | $9.17 | +5,000 | 45.0K | +12% | +$45.9K | |
| 2025-03-21 | 2025-03-19 | ZVRA | ZEVRA THERAPEUTICS, INC. | Bode John B | Dir | P - Purchase | $7.96 | +10.0K | 40.0K | +33% | +$79.6K | |
| 2024-07-15 | 2024-07-12 | ZVRA | ZEVRA THERAPEUTICS, INC. | Bode John B | Dir | P - Purchase | $5.87 | +10.0K | 30.0K | +50% | +$58.7K | |
| 2023-09-06 | 2023-09-05 | ZVRA | ZEVRA THERAPEUTICS, INC. | Bode John B | Dir | P - Purchase | $5.13 | +10.0K | 20.0K | +100% | +$51.3K | |
| M | 2023-05-19 | 2023-05-18 | ZVRA | ZEVRA THERAPEUTICS, INC. | Bode John B | Dir | P - Purchase | $5.04 | +10.0K | 10.0K | New | +$50.4K |
Purchase Sale Sale after option exercise All abbreviations